Concepts (324)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Probiotics | 16 | 2026 | 227 | 7.220 |
Why?
|
| Gastrointestinal Microbiome | 19 | 2026 | 842 | 5.520 |
Why?
|
| Malnutrition | 12 | 2026 | 163 | 4.480 |
Why?
|
| Gastrointestinal Diseases | 8 | 2026 | 343 | 2.770 |
Why?
|
| Intestines | 6 | 2020 | 587 | 2.210 |
Why?
|
| Bile Acids and Salts | 3 | 2025 | 262 | 1.660 |
Why?
|
| Prebiotics | 3 | 2026 | 30 | 1.640 |
Why?
|
| Animals, Newborn | 8 | 2023 | 1021 | 1.540 |
Why?
|
| Bacteria | 6 | 2022 | 521 | 1.450 |
Why?
|
| Gastrointestinal Motility | 3 | 2025 | 65 | 1.400 |
Why?
|
| Microbiota | 3 | 2026 | 438 | 1.270 |
Why?
|
| Gastroparesis | 3 | 2026 | 70 | 1.190 |
Why?
|
| Sex Characteristics | 2 | 2020 | 323 | 1.060 |
Why?
|
| Gastroenterology | 2 | 2020 | 233 | 1.010 |
Why?
|
| Gastrointestinal Tract | 3 | 2026 | 211 | 1.010 |
Why?
|
| Pentanoic Acids | 1 | 2026 | 9 | 0.980 |
Why?
|
| Cholic Acids | 1 | 2026 | 18 | 0.980 |
Why?
|
| Liver | 3 | 2025 | 1796 | 0.950 |
Why?
|
| Cytochrome P450 Family 7 | 1 | 2025 | 4 | 0.910 |
Why?
|
| Steroid Hydroxylases | 1 | 2025 | 19 | 0.900 |
Why?
|
| Sterol Regulatory Element Binding Protein 1 | 1 | 2025 | 31 | 0.900 |
Why?
|
| HIV Infections | 11 | 2015 | 2049 | 0.890 |
Why?
|
| Phage Therapy | 1 | 2025 | 50 | 0.850 |
Why?
|
| Maternal Deprivation | 2 | 2023 | 12 | 0.840 |
Why?
|
| Diarrhea | 3 | 2025 | 301 | 0.810 |
Why?
|
| Child Development | 1 | 2025 | 266 | 0.730 |
Why?
|
| Enterocolitis, Necrotizing | 2 | 2022 | 259 | 0.710 |
Why?
|
| Infant, Premature | 7 | 2024 | 872 | 0.700 |
Why?
|
| Digestive System Physiological Phenomena | 1 | 2020 | 9 | 0.650 |
Why?
|
| Synbiotics | 1 | 2020 | 5 | 0.650 |
Why?
|
| Cholestasis | 1 | 2023 | 170 | 0.640 |
Why?
|
| Intensive Care Units, Neonatal | 1 | 2023 | 361 | 0.630 |
Why?
|
| Infant, Newborn, Diseases | 1 | 2022 | 177 | 0.630 |
Why?
|
| Animals | 21 | 2026 | 33912 | 0.620 |
Why?
|
| Practice Guidelines as Topic | 2 | 2026 | 1295 | 0.600 |
Why?
|
| Escherichia coli Infections | 1 | 2021 | 198 | 0.570 |
Why?
|
| Protein-Energy Malnutrition | 2 | 2016 | 60 | 0.560 |
Why?
|
| Colitis, Ulcerative | 1 | 2021 | 211 | 0.550 |
Why?
|
| Fetal Diseases | 1 | 2022 | 440 | 0.550 |
Why?
|
| Mice | 14 | 2026 | 18301 | 0.540 |
Why?
|
| Fasting | 1 | 2019 | 303 | 0.530 |
Why?
|
| Humans | 52 | 2026 | 131163 | 0.530 |
Why?
|
| T-Lymphocytes | 1 | 2026 | 1722 | 0.520 |
Why?
|
| Mice, Inbred C57BL | 5 | 2026 | 4738 | 0.500 |
Why?
|
| PPAR alpha | 1 | 2017 | 54 | 0.500 |
Why?
|
| Lipogenesis | 1 | 2017 | 61 | 0.490 |
Why?
|
| Gluconeogenesis | 1 | 2017 | 93 | 0.490 |
Why?
|
| Glycolysis | 1 | 2017 | 174 | 0.470 |
Why?
|
| Growth | 1 | 2016 | 93 | 0.460 |
Why?
|
| Anti-Retroviral Agents | 2 | 2014 | 155 | 0.460 |
Why?
|
| Malawi | 12 | 2014 | 348 | 0.460 |
Why?
|
| Enterocytes | 2 | 2012 | 68 | 0.440 |
Why?
|
| Weight Gain | 2 | 2022 | 393 | 0.430 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2017 | 318 | 0.420 |
Why?
|
| Dysbiosis | 3 | 2020 | 145 | 0.420 |
Why?
|
| Infant, Newborn | 12 | 2024 | 8635 | 0.410 |
Why?
|
| Clinical Medicine | 1 | 2014 | 20 | 0.410 |
Why?
|
| Biliary Tract Diseases | 1 | 2013 | 33 | 0.400 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2014 | 141 | 0.380 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2014 | 166 | 0.380 |
Why?
|
| AIDS Serodiagnosis | 1 | 2013 | 52 | 0.380 |
Why?
|
| Inpatients | 3 | 2014 | 562 | 0.370 |
Why?
|
| Colon | 2 | 2026 | 373 | 0.360 |
Why?
|
| Metagenome | 2 | 2012 | 138 | 0.360 |
Why?
|
| Pneumonia | 3 | 2013 | 341 | 0.350 |
Why?
|
| Gastroenteritis | 2 | 2012 | 308 | 0.350 |
Why?
|
| Nutritional Status | 2 | 2014 | 298 | 0.350 |
Why?
|
| Intestinal Mucosa | 3 | 2026 | 771 | 0.340 |
Why?
|
| Male | 29 | 2026 | 64957 | 0.340 |
Why?
|
| Hospital Mortality | 4 | 2014 | 1064 | 0.340 |
Why?
|
| Infant | 19 | 2025 | 13352 | 0.340 |
Why?
|
| Point-of-Care Systems | 1 | 2014 | 214 | 0.340 |
Why?
|
| Female | 29 | 2026 | 70963 | 0.340 |
Why?
|
| Metabolome | 1 | 2013 | 326 | 0.330 |
Why?
|
| Mass Screening | 2 | 2014 | 822 | 0.320 |
Why?
|
| Milk, Human | 3 | 2024 | 321 | 0.320 |
Why?
|
| Drama | 1 | 2010 | 11 | 0.320 |
Why?
|
| Rotavirus Infections | 1 | 2012 | 281 | 0.310 |
Why?
|
| Cell Movement | 2 | 2012 | 876 | 0.310 |
Why?
|
| Infant, Very Low Birth Weight | 2 | 2024 | 176 | 0.310 |
Why?
|
| Consensus | 3 | 2023 | 512 | 0.310 |
Why?
|
| Ambulatory Care | 1 | 2013 | 401 | 0.300 |
Why?
|
| Feces | 4 | 2024 | 721 | 0.300 |
Why?
|
| Liver Diseases | 1 | 2013 | 385 | 0.300 |
Why?
|
| Program Evaluation | 2 | 2012 | 447 | 0.290 |
Why?
|
| Oxidative Stress | 1 | 2013 | 791 | 0.290 |
Why?
|
| Health Education | 1 | 2010 | 228 | 0.270 |
Why?
|
| Body Weight | 1 | 2012 | 987 | 0.270 |
Why?
|
| Inflammation | 2 | 2022 | 1489 | 0.260 |
Why?
|
| Cryptosporidium | 1 | 2007 | 27 | 0.260 |
Why?
|
| Rural Population | 1 | 2010 | 276 | 0.260 |
Why?
|
| Abdominal Pain | 2 | 2026 | 319 | 0.250 |
Why?
|
| Gastric Emptying | 2 | 2026 | 79 | 0.250 |
Why?
|
| Pain Threshold | 1 | 2026 | 24 | 0.250 |
Why?
|
| Tumor Protein p73 | 1 | 2016 | 26 | 0.240 |
Why?
|
| Bacterial Translocation | 1 | 2026 | 30 | 0.240 |
Why?
|
| Evidence-Based Medicine | 2 | 2020 | 645 | 0.240 |
Why?
|
| Protozoan Proteins | 1 | 2007 | 128 | 0.240 |
Why?
|
| Communicable Disease Control | 3 | 2014 | 139 | 0.240 |
Why?
|
| Permeability | 1 | 2026 | 126 | 0.240 |
Why?
|
| Dysentery | 1 | 2025 | 5 | 0.240 |
Why?
|
| Lymphocytes | 1 | 2007 | 344 | 0.230 |
Why?
|
| Food, Fortified | 2 | 2024 | 64 | 0.230 |
Why?
|
| Immune System | 1 | 2026 | 100 | 0.230 |
Why?
|
| Global Health | 1 | 2010 | 626 | 0.230 |
Why?
|
| Immune Tolerance | 1 | 2026 | 151 | 0.230 |
Why?
|
| Muscle, Smooth | 1 | 2025 | 116 | 0.230 |
Why?
|
| Muscle Hypotonia | 1 | 2016 | 194 | 0.220 |
Why?
|
| Interferon-gamma | 1 | 2007 | 544 | 0.220 |
Why?
|
| Myotonic Dystrophy | 1 | 2025 | 73 | 0.220 |
Why?
|
| Child, Preschool | 12 | 2025 | 15110 | 0.210 |
Why?
|
| Recombinant Proteins | 1 | 2007 | 1319 | 0.200 |
Why?
|
| Myenteric Plexus | 1 | 2023 | 12 | 0.200 |
Why?
|
| Hepatocytes | 1 | 2025 | 232 | 0.200 |
Why?
|
| Bacteriophages | 1 | 2025 | 101 | 0.200 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2016 | 354 | 0.200 |
Why?
|
| Vital Signs | 2 | 2013 | 24 | 0.190 |
Why?
|
| Intensive Care, Neonatal | 1 | 2023 | 56 | 0.190 |
Why?
|
| Age Factors | 2 | 2020 | 2825 | 0.190 |
Why?
|
| Ursodeoxycholic Acid | 1 | 2023 | 38 | 0.190 |
Why?
|
| Amidohydrolases | 1 | 2023 | 21 | 0.190 |
Why?
|
| Disease Models, Animal | 5 | 2025 | 4697 | 0.190 |
Why?
|
| Reference Standards | 1 | 2023 | 231 | 0.190 |
Why?
|
| Enterobacteriaceae | 1 | 2023 | 40 | 0.190 |
Why?
|
| Sepsis | 2 | 2020 | 493 | 0.180 |
Why?
|
| RNA, Ribosomal, 16S | 2 | 2015 | 377 | 0.180 |
Why?
|
| Triage | 2 | 2013 | 144 | 0.180 |
Why?
|
| RNA-Binding Proteins | 1 | 2025 | 533 | 0.180 |
Why?
|
| Intestine, Small | 1 | 2024 | 291 | 0.170 |
Why?
|
| Intestinal Diseases | 1 | 2022 | 67 | 0.170 |
Why?
|
| Hospitals | 3 | 2013 | 435 | 0.170 |
Why?
|
| Severity of Illness Index | 4 | 2014 | 3061 | 0.170 |
Why?
|
| Stomach | 1 | 2023 | 274 | 0.170 |
Why?
|
| Causality | 1 | 2021 | 89 | 0.160 |
Why?
|
| Crohn Disease | 1 | 2024 | 292 | 0.160 |
Why?
|
| Gastrointestinal Transit | 1 | 2020 | 32 | 0.160 |
Why?
|
| Infectious Disease Transmission, Vertical | 2 | 2013 | 262 | 0.160 |
Why?
|
| Neurodevelopmental Disorders | 1 | 2016 | 629 | 0.150 |
Why?
|
| Lactoferrin | 1 | 2020 | 76 | 0.150 |
Why?
|
| Neonatal Sepsis | 1 | 2020 | 39 | 0.150 |
Why?
|
| Fluorescein-5-isothiocyanate | 1 | 2019 | 27 | 0.150 |
Why?
|
| Dextrans | 1 | 2019 | 42 | 0.150 |
Why?
|
| Anti-Bacterial Agents | 2 | 2023 | 2596 | 0.150 |
Why?
|
| Intellectual Disability | 1 | 2016 | 1089 | 0.140 |
Why?
|
| Treatment Outcome | 5 | 2026 | 12936 | 0.140 |
Why?
|
| Community Health Workers | 3 | 2015 | 87 | 0.140 |
Why?
|
| Infant Mortality | 1 | 2020 | 183 | 0.140 |
Why?
|
| Cell Differentiation | 1 | 2026 | 1928 | 0.140 |
Why?
|
| Species Specificity | 1 | 2019 | 470 | 0.140 |
Why?
|
| Hospitalization | 4 | 2014 | 1950 | 0.140 |
Why?
|
| Health Status Disparities | 1 | 2021 | 282 | 0.130 |
Why?
|
| Enteral Nutrition | 1 | 2020 | 290 | 0.130 |
Why?
|
| Case-Control Studies | 2 | 2023 | 3359 | 0.130 |
Why?
|
| Genetic Variation | 1 | 2024 | 1559 | 0.130 |
Why?
|
| Mice, Inbred BALB C | 1 | 2019 | 978 | 0.120 |
Why?
|
| Child | 9 | 2025 | 26341 | 0.120 |
Why?
|
| Prospective Studies | 6 | 2024 | 6459 | 0.120 |
Why?
|
| Infant Nutritional Physiological Phenomena | 3 | 2024 | 175 | 0.120 |
Why?
|
| Cresols | 1 | 2016 | 10 | 0.120 |
Why?
|
| Bacteroidetes | 1 | 2016 | 21 | 0.120 |
Why?
|
| Sulfuric Acid Esters | 1 | 2016 | 15 | 0.120 |
Why?
|
| Weaning | 1 | 2016 | 52 | 0.120 |
Why?
|
| Lactates | 1 | 2016 | 82 | 0.120 |
Why?
|
| Oxidation-Reduction | 1 | 2017 | 436 | 0.120 |
Why?
|
| Polymerase Chain Reaction | 3 | 2014 | 1447 | 0.120 |
Why?
|
| Quality of Life | 1 | 2026 | 2082 | 0.120 |
Why?
|
| Urinary Tract Infections | 1 | 2020 | 342 | 0.110 |
Why?
|
| Biomarkers | 2 | 2016 | 3385 | 0.110 |
Why?
|
| Health Services Research | 2 | 2013 | 180 | 0.110 |
Why?
|
| Escherichia coli | 1 | 2021 | 991 | 0.110 |
Why?
|
| Polysaccharides | 1 | 2016 | 143 | 0.110 |
Why?
|
| Metagenomics | 1 | 2016 | 116 | 0.110 |
Why?
|
| Dietary Supplements | 3 | 2024 | 448 | 0.110 |
Why?
|
| Serotonin | 1 | 2016 | 208 | 0.110 |
Why?
|
| Arm | 1 | 2014 | 71 | 0.110 |
Why?
|
| World Health Organization | 1 | 2014 | 118 | 0.110 |
Why?
|
| Child Nutrition Disorders | 1 | 2014 | 41 | 0.110 |
Why?
|
| Fatty Acids | 1 | 2017 | 377 | 0.100 |
Why?
|
| Pregnancy, Unplanned | 1 | 2014 | 9 | 0.100 |
Why?
|
| Anthropometry | 1 | 2014 | 187 | 0.100 |
Why?
|
| Hydroxybutyrates | 1 | 2013 | 31 | 0.100 |
Why?
|
| Text Messaging | 1 | 2014 | 42 | 0.100 |
Why?
|
| gamma-Glutamyltransferase | 1 | 2013 | 49 | 0.100 |
Why?
|
| Contraceptive Agents, Female | 1 | 2014 | 31 | 0.100 |
Why?
|
| Reminder Systems | 1 | 2014 | 62 | 0.100 |
Why?
|
| Disease Transmission, Infectious | 1 | 2014 | 71 | 0.100 |
Why?
|
| DNA, Bacterial | 1 | 2015 | 481 | 0.100 |
Why?
|
| Random Allocation | 1 | 2014 | 409 | 0.100 |
Why?
|
| Drug Interactions | 1 | 2014 | 237 | 0.100 |
Why?
|
| Allied Health Personnel | 1 | 2013 | 33 | 0.100 |
Why?
|
| Oxygen Inhalation Therapy | 1 | 2013 | 88 | 0.090 |
Why?
|
| Mice, Inbred Strains | 1 | 2012 | 263 | 0.090 |
Why?
|
| Thinness | 1 | 2012 | 71 | 0.090 |
Why?
|
| Genomics | 1 | 2020 | 1621 | 0.090 |
Why?
|
| Tuberculosis, Pulmonary | 1 | 2014 | 238 | 0.090 |
Why?
|
| Health Resources | 1 | 2013 | 131 | 0.090 |
Why?
|
| Oximetry | 1 | 2013 | 176 | 0.090 |
Why?
|
| Delivery of Health Care, Integrated | 1 | 2013 | 146 | 0.090 |
Why?
|
| Hypoxia | 1 | 2013 | 247 | 0.080 |
Why?
|
| Health Personnel | 2 | 2013 | 541 | 0.080 |
Why?
|
| Antibodies | 1 | 2012 | 322 | 0.080 |
Why?
|
| Inflammation Mediators | 1 | 2012 | 226 | 0.080 |
Why?
|
| DNA Primers | 1 | 2012 | 599 | 0.080 |
Why?
|
| Developing Countries | 1 | 2013 | 305 | 0.080 |
Why?
|
| Esophageal Diseases | 1 | 2011 | 38 | 0.080 |
Why?
|
| Meningitis | 1 | 2011 | 96 | 0.080 |
Why?
|
| Haiti | 1 | 2010 | 10 | 0.080 |
Why?
|
| Poverty Areas | 1 | 2010 | 37 | 0.080 |
Why?
|
| Mycobacterium tuberculosis | 1 | 2014 | 430 | 0.080 |
Why?
|
| Phylogeny | 1 | 2012 | 689 | 0.080 |
Why?
|
| Evaluation Studies as Topic | 1 | 2010 | 225 | 0.080 |
Why?
|
| Rotavirus | 1 | 2012 | 367 | 0.080 |
Why?
|
| HIV | 1 | 2011 | 174 | 0.080 |
Why?
|
| Candidiasis | 1 | 2011 | 134 | 0.080 |
Why?
|
| Sarcoma, Kaposi | 1 | 2011 | 129 | 0.080 |
Why?
|
| Overweight | 1 | 2012 | 387 | 0.070 |
Why?
|
| Time Factors | 1 | 2019 | 6196 | 0.070 |
Why?
|
| Educational Status | 1 | 2010 | 279 | 0.070 |
Why?
|
| Immunohistochemistry | 1 | 2012 | 1591 | 0.070 |
Why?
|
| Hospitals, Pediatric | 1 | 2013 | 808 | 0.070 |
Why?
|
| Base Sequence | 1 | 2012 | 2730 | 0.070 |
Why?
|
| Adult | 8 | 2026 | 31282 | 0.060 |
Why?
|
| Acute Disease | 1 | 2010 | 1153 | 0.060 |
Why?
|
| DNA Methylation | 1 | 2013 | 1077 | 0.060 |
Why?
|
| Anemia | 1 | 2011 | 354 | 0.060 |
Why?
|
| Pregnancy Complications | 1 | 2012 | 567 | 0.060 |
Why?
|
| Young Adult | 5 | 2026 | 10103 | 0.060 |
Why?
|
| Rats | 2 | 2010 | 3370 | 0.060 |
Why?
|
| Cytokines | 1 | 2012 | 1339 | 0.060 |
Why?
|
| Chronic Disease | 1 | 2010 | 1246 | 0.060 |
Why?
|
| Nausea | 1 | 2026 | 83 | 0.060 |
Why?
|
| Myotonin-Protein Kinase | 1 | 2025 | 25 | 0.060 |
Why?
|
| Vomiting | 1 | 2026 | 103 | 0.060 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2020 | 1267 | 0.060 |
Why?
|
| Muscle Contraction | 1 | 2025 | 147 | 0.060 |
Why?
|
| Cell Proliferation | 1 | 2012 | 2465 | 0.060 |
Why?
|
| Pain Measurement | 1 | 2026 | 353 | 0.050 |
Why?
|
| Transcriptome | 1 | 2012 | 1103 | 0.050 |
Why?
|
| Health Services Accessibility | 1 | 2011 | 712 | 0.050 |
Why?
|
| Obesity | 1 | 2016 | 2426 | 0.050 |
Why?
|
| Proteobacteria | 1 | 2024 | 16 | 0.050 |
Why?
|
| Adolescent | 6 | 2026 | 20987 | 0.050 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2010 | 919 | 0.050 |
Why?
|
| CD8 Antigens | 1 | 2003 | 39 | 0.050 |
Why?
|
| Meta-Analysis as Topic | 1 | 2023 | 169 | 0.050 |
Why?
|
| Pancreatic Elastase | 1 | 2022 | 11 | 0.050 |
Why?
|
| Reference Values | 2 | 2014 | 676 | 0.050 |
Why?
|
| Child, Hospitalized | 2 | 2013 | 76 | 0.050 |
Why?
|
| Cecum | 1 | 2022 | 26 | 0.050 |
Why?
|
| Cells, Cultured | 1 | 2007 | 2885 | 0.040 |
Why?
|
| Spinal Cord | 1 | 2003 | 255 | 0.040 |
Why?
|
| Mutation, Missense | 1 | 2016 | 919 | 0.040 |
Why?
|
| Risk Factors | 2 | 2013 | 11074 | 0.040 |
Why?
|
| Cohort Studies | 1 | 2011 | 5063 | 0.040 |
Why?
|
| Exome | 1 | 2016 | 1061 | 0.040 |
Why?
|
| Health | 1 | 2021 | 35 | 0.040 |
Why?
|
| Publications | 1 | 2021 | 36 | 0.040 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2016 | 889 | 0.040 |
Why?
|
| Middle Aged | 4 | 2026 | 28601 | 0.040 |
Why?
|
| Retrospective Studies | 4 | 2013 | 17753 | 0.040 |
Why?
|
| Pregnancy | 4 | 2015 | 7512 | 0.040 |
Why?
|
| Lipopolysaccharides | 1 | 2022 | 299 | 0.040 |
Why?
|
| Disease | 1 | 2021 | 121 | 0.040 |
Why?
|
| Spinal Cord Injuries | 1 | 2003 | 273 | 0.040 |
Why?
|
| Infant, Low Birth Weight | 1 | 2020 | 172 | 0.040 |
Why?
|
| Anti-HIV Agents | 2 | 2013 | 345 | 0.040 |
Why?
|
| Infant Health | 1 | 2019 | 17 | 0.040 |
Why?
|
| Referral and Consultation | 2 | 2013 | 564 | 0.040 |
Why?
|
| Macrophages | 1 | 2003 | 667 | 0.040 |
Why?
|
| Pilot Projects | 2 | 2014 | 1445 | 0.040 |
Why?
|
| Biodiversity | 1 | 2019 | 73 | 0.040 |
Why?
|
| Registries | 1 | 2026 | 1634 | 0.040 |
Why?
|
| Weight Loss | 1 | 2022 | 538 | 0.030 |
Why?
|
| Mice, Knockout | 1 | 2025 | 3819 | 0.030 |
Why?
|
| Aged | 2 | 2026 | 21025 | 0.030 |
Why?
|
| Mental Health | 1 | 2021 | 378 | 0.030 |
Why?
|
| DNA-Binding Proteins | 1 | 2025 | 1939 | 0.030 |
Why?
|
| Surveys and Questionnaires | 1 | 2026 | 4066 | 0.030 |
Why?
|
| Prevalence | 2 | 2014 | 2701 | 0.030 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2024 | 2833 | 0.030 |
Why?
|
| Kenya | 1 | 2014 | 60 | 0.030 |
Why?
|
| Nevirapine | 1 | 2014 | 15 | 0.030 |
Why?
|
| Lopinavir | 1 | 2014 | 9 | 0.030 |
Why?
|
| Sputum | 1 | 2014 | 113 | 0.030 |
Why?
|
| Benzoxazines | 1 | 2014 | 23 | 0.030 |
Why?
|
| Alkynes | 1 | 2014 | 27 | 0.030 |
Why?
|
| Microscopy | 1 | 2014 | 118 | 0.030 |
Why?
|
| Ritonavir | 1 | 2014 | 46 | 0.030 |
Why?
|
| Cyclopropanes | 1 | 2014 | 70 | 0.030 |
Why?
|
| Premedication | 1 | 2013 | 39 | 0.020 |
Why?
|
| Respiration | 1 | 2013 | 117 | 0.020 |
Why?
|
| Confidence Intervals | 1 | 2013 | 272 | 0.020 |
Why?
|
| CD4 Lymphocyte Count | 1 | 2013 | 227 | 0.020 |
Why?
|
| Nutrition Surveys | 1 | 2014 | 338 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2024 | 3436 | 0.020 |
Why?
|
| Area Under Curve | 1 | 2013 | 304 | 0.020 |
Why?
|
| Temperature | 1 | 2013 | 291 | 0.020 |
Why?
|
| Community Networks | 1 | 2012 | 30 | 0.020 |
Why?
|
| Workload | 1 | 2013 | 151 | 0.020 |
Why?
|
| ROC Curve | 1 | 2013 | 613 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2013 | 1211 | 0.020 |
Why?
|
| Heart Rate | 1 | 2013 | 577 | 0.020 |
Why?
|
| Respiratory Tract Infections | 1 | 2013 | 298 | 0.020 |
Why?
|
| Oxygen | 1 | 2013 | 548 | 0.020 |
Why?
|
| Antiretroviral Therapy, Highly Active | 1 | 2011 | 256 | 0.020 |
Why?
|
| Prenatal Care | 1 | 2012 | 345 | 0.020 |
Why?
|
| Medical Records Systems, Computerized | 1 | 2010 | 138 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2014 | 2304 | 0.020 |
Why?
|
| Communication | 1 | 2013 | 543 | 0.020 |
Why?
|
| Logistic Models | 1 | 2013 | 1797 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2013 | 2085 | 0.020 |
Why?
|
| Longitudinal Studies | 1 | 2012 | 1490 | 0.020 |
Why?
|
| Urban Population | 1 | 2010 | 287 | 0.020 |
Why?
|
| Quality Improvement | 1 | 2013 | 722 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2013 | 3829 | 0.010 |
Why?
|
| Radiation Chimera | 1 | 2003 | 16 | 0.010 |
Why?
|
| Rats, Inbred BN | 1 | 2003 | 16 | 0.010 |
Why?
|
| Rats, Inbred Lew | 1 | 2003 | 59 | 0.010 |
Why?
|
| CD4 Antigens | 1 | 2003 | 54 | 0.010 |
Why?
|
| Algorithms | 1 | 2010 | 1680 | 0.010 |
Why?
|
| Leukocytes | 1 | 2003 | 205 | 0.010 |
Why?
|
| Microglia | 1 | 2003 | 147 | 0.010 |
Why?
|
| Pediatrics | 1 | 2010 | 1252 | 0.010 |
Why?
|
| Disease Progression | 1 | 2003 | 2200 | 0.010 |
Why?
|